Europe PMC
Cure8 research brief
Why This Matters
The study identifies osteopontin as a stromal-secreted protein elevated in IBD-derived colonic fibroblasts and shows it can restrain epithelial maturation in human colonic organoids, a mechanistic insight that could be relevant for mucosal healing in IBD.
Who Should Pay Attention
Researchers, translational scientists, and clinicians interested in epithelial-stromal biology and mucosal repair in IBD.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The study compared conditioned media from fibroblast cultures derived from inflamed versus noninflamed human colon and found consistently higher OPN in the inflamed-associated fibroblast group.
The authors then added recombinant OPN to human colonic organoids (three donors) and observed changes indicating impaired epithelial maturation; effects on organoid growth and proliferation varied with culture conditions. The work is laboratory-based (human primary cells and organoids) and presented as a preprint abstract-level report.
It demonstrates a plausible mechanism but does not provide clinical outcomes, therapeutic testing, or patient-level data.
Keep In Mind
Preprint/abstract-level laboratory study using limited donor-derived fibroblast cultures and organoids; not peer-reviewed and not a clinical trial.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationEurope PMC
AuthorsHamel D, Quaranta M, Bonnet D +2 more
Study typePreprint
Indexed viaEurope PMC
Source typeResearch paper
PublishedSep 3, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
A preliminary study of HMGB1 defense in Crohn's disease
The finding links a specific mucus-associated protein (HMGB1) to barrier defects in Crohn’s disease, which could help explain how bacteria reach and inflame tissue in active lesions and point to future biomarker or...
Mucosal ecosystems of the ileum and colon shape the therapeutic response in Crohn's Disease
The study maps cell-level programs in ileum and colon that associate with failure to respond to biologic therapies, suggesting specific cellular markers and niches that could help explain treatment resistance and guide...
An atlas of colonization factors in the human gut microbiome reveals ecological strategies and inflammatory bowel disease signatures
This study identifies conserved, gut-enriched genes (colonization factors) and shows their repertoires are remodeled in IBD, highlighting functional microbiome changes that could inform future biomarkers or...